Clinical Trials in North Carolina

Showing 18301-18320 of 20,428 trials

Dexamethasone Followed by Denileukin Diftitox in Treating Patients With Persistent or Recurrent T-Cell Lymphoma

NCT00006345

RATIONALE: Denileukin diftitox may be able to deliver cancer-killing substances directly to T-cell lymphoma cells. Dexamethasone may decrease the side effects of denileukin diftitox. PURPOSE: Phase II trial to study the effectiveness of dexamethasone in preventing side effects following treatment with denileukin diftitox in treating patients who have persistent or recurrent T-cell lymphoma.

Drug/Agent Toxicity by Tissue/OrganLymphoma

Ligand PharmaceuticalsStarted Nov 1999

Miami, Florida, United States • Chicago, Illinois, United States • New Orleans, Louisiana, United States +8 more locations

COMPLETED41 miles

Quality of Life in Survivors of Gynecologic Cancer

NCT00003795

RATIONALE: Quality-of-life assessment in cancer survivors may help determine the long-term effects of having had gynecologic cancer and may help improve the quality of life for future cancer survivors. PURPOSE: This clinical trial is studying the quality of life in survivors of gynecologic cancer.

Endometrial CancerOvarian Cancer

Gynecologic Oncology Group311 participantsStarted Apr 1999

Birmingham, Alabama, United States • Los Angeles, California, United States • Los Gatos, California, United States +41 more locations

Dexamethasone Followed by Denileukin Diftitox in Treating Patients With Persistent or Recurrent T-Cell Lymphoma

Quality of Life in Survivors of Gynecologic Cancer

Find Trials by Condition in North Carolina

Combination Chemotherapy in Treating Patients With Stage III or Stage IV Ovarian Epithelial or Primary Peritoneal Cancer

Paclitaxel and Cisplatin in Treating Patients With Stage III or Stage IV Ovarian Cancer or Primary Peritoneal Cancer

Capecitabine in Treating Patients With Advanced, Persistent, or Recurrent Cervical Cancer

Irofulven in Treating Patients With Persistent or Recurrent, Refractory Endometrial Cancer

Single Injection of REGN475/SAR164877 in the Treatment of Chronic Pancreatitis Pain

Vascular Endothelial Growth Factor (VEGF) Trap-Eye: Investigation of Efficacy and Safety in Central Retinal Vein Occlusion (CRVO)

Factors Affecting Adherence to Anti-HIV Drug Regimens in Children and Adolescents

A Treatment Protocol For Patients Continuing From A Prior SU011248 Protocol.

Fecal Biomarker Study for Patients With Ulcerative Colitis

SWOG-9245 Collecting and Storing Tissue Samples From Patients With Relapsed or Recurrent Non-Hodgkin Lymphoma After Treatment on a Southwest Oncology Group Clinical Trial

Stress Management Training in Patients Undergoing Radiation Therapy for Cancer

Study of the Safety and Tolerability of PCI-32765 in Patients With Recurrent B Cell Lymphoma

Chemotherapy Plus Monoclonal Antibody Therapy in Treating Women With Stage II or Stage IIIA Breast Cancer That Overexpresses HER2

Clinical Efficacy Study Comparing VisionScope Imaging (VSI) to Magnetic Resonance Imaging (MRI) in Injuries of the Knee

Sorafenib/Docetaxel Dose Escalation Trial

Pilot Study Evaluating the Safety and Performance of the GeNO NITROsyl Delivery System for Inhaled Nitric Oxide

Study of the Safety and Pharmacokinetics of XL765 (SAR245409) in Adults With Solid Tumors

Study of MDX-1342 in Patients With Chronic Lymphocytic Leukemia (CLL)